Charles Schwab Investment Management Inc Ideaya Biosciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 689,073 shares of IDYA stock, worth $17.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
689,073
Previous 610,555
12.86%
Holding current value
$17.9 Million
Previous $21.4 Million
1.83%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IDYA
# of Institutions
215Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$177 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$135 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$134 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$125 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$104 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.25B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...